medical research – The Milli Chronicle

Tuesday, November 4, 2025

Latest:

Saudi Arabia Strengthens Public Safety with Nationwide Early Warning System Tests
Jeddah’s Cultural Renaissance Captivates Global Audience at London’s World Travel Market
Saudi Students Gain Hands-On Experience in Restoring Historic Mosques Through National Heritage Program
Saudi Foreign Minister Joins Regional Leaders in Istanbul Talks to Advance Peace Efforts in Gaza
Saudi Forum Champions “Sufficiency Before Efficiency” at UN Climate Conference in Brazil

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle November 4, 2025 Center for Drug Evaluation and Research, clinical trials, drug approval process, drug safety, ethical governance, FDA ethics, FDA leadership change, FDA modernization, FDA reform, Food and Drug Administration, global drug safety, health policy, healthcare transparency, medical innovation, medical research, pharmaceutical innovation, pharmaceutical regulation, public health, Robert F. Kennedy Jr., U.S. health agencies, US FDA

US FDA’s Drug Division Undergoes Leadership Transition to Strengthen Integrity and Innovation

The U.S. Food and Drug Administration begins a new chapter in its drug evaluation and research division, focusing on ethics,

Featured Health Lifestyle

NewsDesk Milli Chronicle October 10, 2025 biotech mergers 2025, biotechnology acquisition, drug development news, global biotech investments, healthcare innovation, J&J biotech expansion, J&J pharma growth, Janssen Biotech collaboration, Johnson & Johnson acquisition, Johnson & Johnson news, Johnson & Johnson strategy., medical research, peptide-based drugs, pharmaceutical innovation, polycythemia vera treatment, Protagonist stock surge, Protagonist Therapeutics, rare disease therapy, Rusfertide PTG-300, WSJ report

Johnson & Johnson Eyes Major Leap in Biotech: Talks Underway to Acquire Protagonist Therapeutics in Billion-Dollar Move

In a bold bid to expand its cutting-edge drug pipeline, Johnson & Johnson is reportedly in advanced talks to acquire